WO2005050223A3 - Proteome epitope tags and methods of use thereof in protein modification analysis - Google Patents
Proteome epitope tags and methods of use thereof in protein modification analysis Download PDFInfo
- Publication number
- WO2005050223A3 WO2005050223A3 PCT/US2004/038283 US2004038283W WO2005050223A3 WO 2005050223 A3 WO2005050223 A3 WO 2005050223A3 US 2004038283 W US2004038283 W US 2004038283W WO 2005050223 A3 WO2005050223 A3 WO 2005050223A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- epitope tags
- protein modification
- proteins
- modification analysis
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004292226A AU2004292226B2 (en) | 2003-11-13 | 2004-11-15 | Proteome epitope tags and methods of use thereof in protein modification analysis |
JP2006539990A JP2007511837A (en) | 2003-11-13 | 2004-11-15 | Proteome epitome tags and their use in protein modification analysis |
EP04811121A EP1683065A2 (en) | 2003-11-13 | 2004-11-15 | Proteome epitope tags and methods of use thereof in protein modification analysis |
CA002545899A CA2545899A1 (en) | 2003-11-13 | 2004-11-15 | Proteome epitope tags and methods of use thereof in protein modification analysis |
AU2008227063A AU2008227063A1 (en) | 2003-11-13 | 2008-09-25 | Proteome epitome tags and methods of use thereof in protein modification analysis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/712,425 US7460960B2 (en) | 2002-05-10 | 2003-11-13 | Proteome epitope tags and methods of use thereof in protein modification analysis |
US10/712,425 | 2003-11-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005050223A2 WO2005050223A2 (en) | 2005-06-02 |
WO2005050223A3 true WO2005050223A3 (en) | 2006-02-09 |
Family
ID=34619853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/038283 WO2005050223A2 (en) | 2003-11-13 | 2004-11-15 | Proteome epitope tags and methods of use thereof in protein modification analysis |
Country Status (6)
Country | Link |
---|---|
US (2) | US7460960B2 (en) |
EP (1) | EP1683065A2 (en) |
JP (1) | JP2007511837A (en) |
AU (2) | AU2004292226B2 (en) |
CA (1) | CA2545899A1 (en) |
WO (1) | WO2005050223A2 (en) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030113744A1 (en) * | 2001-05-11 | 2003-06-19 | O' Toole Margot M. | Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof |
AU2002365421A1 (en) | 2001-07-10 | 2003-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting the activation state of the multiple proteins in single cells |
US7381535B2 (en) * | 2002-07-10 | 2008-06-03 | The Board Of Trustees Of The Leland Stanford Junior | Methods and compositions for detecting receptor-ligand interactions in single cells |
US7695926B2 (en) | 2001-07-10 | 2010-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting receptor-ligand interactions in single cells |
US7393656B2 (en) * | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
FI118061B (en) * | 2001-09-24 | 2007-06-15 | Beanor Oy | Procedure and bio donor for analysis |
FI115166B (en) * | 2001-12-31 | 2005-03-15 | Biofons Oy | Diagnostic procedures |
AU2003299478A1 (en) | 2002-05-07 | 2004-05-25 | Regents Of The University Of California | Bioactivation of particles |
US7618788B2 (en) * | 2002-05-10 | 2009-11-17 | Millipore Corporation | Proteome epitope tags and methods of use thereof in protein modification analysis |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
US7632686B2 (en) * | 2002-10-03 | 2009-12-15 | Anderson Forschung Group | High sensitivity quantitation of peptides by mass spectrometry |
US7846748B2 (en) * | 2002-12-02 | 2010-12-07 | The University Of North Carolina At Chapel Hill | Methods of quantitation and identification of peptides and proteins |
WO2005032453A2 (en) * | 2003-04-28 | 2005-04-14 | Sequoia Pharmaceuticals, Inc. | Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
US7425700B2 (en) * | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
US7790473B2 (en) * | 2003-11-05 | 2010-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Biofunctionalized quantum dots for biological imaging |
US7780873B2 (en) * | 2004-02-23 | 2010-08-24 | Texas A&M University System | Bioactive complexes compositions and methods of use thereof |
EP1766388A4 (en) * | 2004-06-09 | 2008-08-20 | Anderson Forschung Group Llc | Stable isotope labeled polypeptide standards for protein quantitation |
WO2006093516A2 (en) * | 2004-06-22 | 2006-09-08 | The Regents Of The University Of California | Peptide-coated nanoparticles with graded shell compositions |
CA2520670A1 (en) * | 2004-09-23 | 2006-03-23 | National Research Council Of Canada | Nanocrystal coated surfaces |
WO2006040107A1 (en) * | 2004-10-12 | 2006-04-20 | Schott Ag | Multiplexed protein adsorption assay |
US20070009923A1 (en) * | 2005-01-24 | 2007-01-11 | Massachusetts Institute Of Technology | Use of bayesian networks for modeling cell signaling systems |
JP2006248978A (en) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
US20060223194A1 (en) * | 2005-04-01 | 2006-10-05 | Viorica Lopez-Avila | Methods of screening for post-translationally modified proteins |
US20060223130A1 (en) * | 2005-04-04 | 2006-10-05 | Dan-Hui Yang | Detection of post-translationally modified analytes |
US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
BRPI0619492A2 (en) * | 2005-12-07 | 2011-10-04 | Univ Ramot | jasmonate chemical derivatives, pharmaceutical compositions and methods of use |
US7855057B2 (en) | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
US20100331200A1 (en) * | 2006-03-31 | 2010-12-30 | Gordon Neal F | Post translational modification pattern analysis |
WO2009134944A2 (en) * | 2008-04-29 | 2009-11-05 | Nodality, Inc. | Methods of determining the health status of an individual |
US20090291458A1 (en) * | 2008-05-22 | 2009-11-26 | Nodality, Inc. | Method for Determining the Status of an Individual |
WO2010006291A1 (en) * | 2008-07-10 | 2010-01-14 | Nodality, Inc. | Methods for diagnosis, prognosis and treatment |
US8399206B2 (en) | 2008-07-10 | 2013-03-19 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20100099109A1 (en) * | 2008-10-17 | 2010-04-22 | Nodality, Inc., A Delaware Corporation | Methods for Analyzing Drug Response |
US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
KR101061017B1 (en) * | 2009-10-23 | 2011-08-31 | (주) 수파드엘릭사 | Pharmaceutical composition for inhibiting growth and / or metastasis of cancer cells |
KR101341640B1 (en) * | 2010-02-05 | 2013-12-16 | 한국전자통신연구원 | The analying method of protein microstructure and array for the same |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
JPWO2012026309A1 (en) * | 2010-08-23 | 2013-10-28 | 公立大学法人横浜市立大学 | Creation of anti-PAD4 antibody drugs |
WO2012027555A2 (en) | 2010-08-25 | 2012-03-01 | President And Fellows Of Harvard College | Glycated cd59 peptides, their preparation, and uses thereof |
US9383367B1 (en) | 2010-12-07 | 2016-07-05 | Chunli Liu | Methods of detecting conjugation site-specific and hidden epitope/antigen |
US9417248B2 (en) | 2011-02-10 | 2016-08-16 | President And Fellows Of Harvard College | Surrogates of post-translationally modified proteins and uses thereof |
US9023599B2 (en) * | 2011-09-25 | 2015-05-05 | Chang Gung Medical Foundation, Linkou Branch | Method of detecting the presence of pneumococcal neuraminidases in Streptococcus pneumoniae-infected samples |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
CA2928359A1 (en) * | 2013-10-21 | 2015-04-30 | The Research Foundation For The State University Of New York | Peptide inhibitor of hiv reverse transcription |
CN103698509B (en) * | 2014-01-08 | 2017-02-08 | 青岛科技大学 | Method for detecting mercaptoacetic acid by utilizing electrochemical immunosensor sensor based on nano porous gold electrode |
US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
KR101750407B1 (en) | 2014-11-10 | 2017-06-27 | 한양대학교 산학협력단 | Phosphorylated Peptide-Specific RNA Aptamer |
US10006906B2 (en) | 2015-02-27 | 2018-06-26 | Regents Of The University Of Minnesota | Detection assays and methods |
JP6548981B2 (en) * | 2015-07-14 | 2019-07-24 | 地方独立行政法人東京都立産業技術研究センター | Surface plasmon resonance measuring device and its chip |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US10520514B2 (en) * | 2017-02-01 | 2019-12-31 | Korea Institute Of Science And Technology | Method for monitoring post-translational modification of protein |
US11866506B2 (en) | 2017-04-21 | 2024-01-09 | Mellitus, Llc | Anti-CD59 antibodies |
EP3404567A1 (en) * | 2017-05-19 | 2018-11-21 | Fujitsu Limited | A system and a method for discovery of predicted site-specific protein phosphorylation candidates |
CA3071894A1 (en) * | 2017-08-04 | 2019-02-07 | Abcam Plc | Methods and compositions for the development of antibodies specific to epitope post-translational modification status |
CN108776231B (en) * | 2018-09-06 | 2020-12-29 | 长沙文瀚生物技术有限责任公司 | Human urinary albumin latex-enhanced secondary antibody competitive immunoturbidimetry detection kit and manufacturing and using methods thereof |
EP3640864A1 (en) | 2018-10-18 | 2020-04-22 | Fujitsu Limited | A computer-implemented method and apparatus for inferring a property of a biomedical entity |
CN110209770B (en) * | 2019-06-03 | 2022-04-15 | 北京邮电大学 | Named entity identification method based on strategy value network and tree search enhancement |
WO2021026172A1 (en) | 2019-08-05 | 2021-02-11 | Seer, Inc. | Systems and methods for sample preparation, data generation, and protein corona analysis |
CN113899902A (en) * | 2020-06-22 | 2022-01-07 | 上海科技大学 | Tyrosine phosphatase substrate identification method |
CN112305041B (en) * | 2020-09-15 | 2022-05-27 | 东莞东阳光医疗智能器件研发有限公司 | Multiple quantitative electrochemical immunosensor and construction method thereof |
US20230358737A1 (en) * | 2020-09-24 | 2023-11-09 | University Of Cincinnati | Continuously chemically enhanced aptamer sensors |
US11617741B1 (en) | 2021-08-12 | 2023-04-04 | Health Research, Inc. | Method for inhibiting growth of bacteria |
WO2023025263A1 (en) * | 2021-08-25 | 2023-03-02 | Ensem Therapeutics Holding (Singapore) Pte. Ltd. | Systems and methods for post-translational modification-inspired drug design and screening |
JP2023121226A (en) * | 2022-02-21 | 2023-08-31 | 株式会社日立製作所 | Sample pretreatment method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997007132A1 (en) * | 1995-08-15 | 1997-02-27 | Commonwealth Scientific And Industrial Research Organisation | Epitope tagging system |
US20020137119A1 (en) * | 2001-01-14 | 2002-09-26 | Katz Emil Israel | Peptides representative of polypeptides of interest and antibodies directed thereagainst, and methods, systems and kits for generating and utilizing each |
WO2004046164A2 (en) * | 2002-05-10 | 2004-06-03 | Engeneos, Inc. | Unique recognition sequences and methods of use thereof in protein analysis |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4478744A (en) | 1982-01-25 | 1984-10-23 | Sherwood Medical Company | Method of obtaining antibodies |
US4658022A (en) | 1985-08-08 | 1987-04-14 | Molecular Diagnostics, Inc. | Binding of antibody reagents to denatured protein analytes |
US5223441A (en) * | 1986-10-09 | 1993-06-29 | Syntex (U.S.A.) Inc. | Receptors for immune complexes |
EP0267355B1 (en) | 1986-11-10 | 1991-09-18 | PROGEN Biotechnik GmbH | Process for identifying tissue-specific insoluble cytoskeletal proteins |
DE3815932A1 (en) | 1988-01-26 | 1989-08-03 | Progen Biotechnik Gmbh | METHOD FOR IDENTIFYING THE ORIGIN OF A CELL TISSUE SAMPLE |
US4970171A (en) * | 1987-11-09 | 1990-11-13 | Miles Inc. | Denaturant reagents for convenient determination of hemoglobin derivatives in blood |
US5519120A (en) | 1989-04-07 | 1996-05-21 | Cancerforskningsfondet Af 1989 | Urokinase-type plasminogen activator receptor antibodies |
US5849531A (en) | 1989-04-07 | 1998-12-15 | University Of Saskatchewan | Compositions and treatments for pneumonia in animals |
US6955915B2 (en) * | 1989-06-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus comprising polymers |
US5061790A (en) * | 1989-07-10 | 1991-10-29 | Molecular Diagnostics, Inc. | Oxidative denaturation of protein analytes |
DE4009848A1 (en) * | 1990-03-27 | 1991-10-02 | Boehringer Mannheim Gmbh | METHOD FOR DETECTING PROTEINS CONTAINING PHOSPHORYLATED TYROSINE |
FR2660757B1 (en) | 1990-04-06 | 1994-05-27 | Immunotech Sa | METHOD OF IDENTIFYING OR DETERMINING PROTEINS AND APPLICATIONS. |
DE4023945A1 (en) | 1990-07-27 | 1992-01-30 | Progen Biotechnik Gmbh | METHOD FOR PURIFYING CYTOKERATIN 20 AND THE USE THEREOF FOR PRODUCING ANTIBODIES |
US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
WO1993008290A1 (en) | 1991-10-16 | 1993-04-29 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5723129A (en) | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US6261569B1 (en) | 1992-08-27 | 2001-07-17 | Deakin Research Limited | Retro-, inverso- and retro-inverso synthetic peptide analogues |
WO1994008597A1 (en) | 1992-10-14 | 1994-04-28 | The Scripps Research Institute | Methods for the detection of antigen-specific immune complexes |
US5955317A (en) | 1993-01-25 | 1999-09-21 | Takeda Chemical Industries, Ltd. | Antibodies to β-amyloids or their derivatives and use thereof |
JPH07285999A (en) | 1993-03-30 | 1995-10-31 | Prima Meat Packers Ltd | Quantitative analysis of lactoprotein content in food by using elisa, monoclonal antibody selected for the analysis and selection of the monoclonal antibody |
JP3393889B2 (en) | 1993-06-11 | 2003-04-07 | 柳川精工株式会社 | Manufacturing method of non-lubricated bearing and non-lubricated bearing |
CA2164728A1 (en) | 1993-06-22 | 1995-01-05 | Helmut Ponta | Processes for diagnosing and analysing tumours |
WO1996005847A1 (en) | 1994-08-22 | 1996-02-29 | The Trustees Of The University Of Pennsylvania | A method of sequencing proteins by epitope ordering and protein restriction mapping |
WO1996029629A2 (en) | 1995-03-01 | 1996-09-26 | President And Fellows Of Harvard College | Microcontact printing on surfaces and derivative articles |
US5961923A (en) | 1995-04-25 | 1999-10-05 | Irori | Matrices with memories and uses thereof |
JP3452111B2 (en) | 1995-11-10 | 2003-09-29 | セイコーエプソン株式会社 | Ink jet recording head |
US6420125B1 (en) | 1996-03-21 | 2002-07-16 | Osteometer Biotech A/S | Assaying fragments of collagen in body fluids |
US5763158A (en) | 1997-02-06 | 1998-06-09 | The United States Of America As Represented By The Secretary Of The Army | Detection of multiple antigens or antibodies |
NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
US5872234A (en) | 1997-06-27 | 1999-02-16 | Incyte Pharmaceuticals, Inc. | Human extracellular matrix proteins |
US6253456B1 (en) * | 1997-11-17 | 2001-07-03 | Phillip Cooksey | Basketball court layout device and method |
US6809184B1 (en) | 1997-12-01 | 2004-10-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
DE19802576B4 (en) | 1998-01-23 | 2004-10-28 | Xerion Pharmaceuticals Ag | Methods for the simultaneous identification of proteins and their binding partners |
JP2002502038A (en) | 1998-01-29 | 2002-01-22 | ミラー,サミュエル | High density arrays for proteome analysis and methods and compositions therefor |
US6897073B2 (en) | 1998-07-14 | 2005-05-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
US20020119579A1 (en) | 1998-07-14 | 2002-08-29 | Peter Wagner | Arrays devices and methods of use thereof |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6197599B1 (en) | 1998-07-30 | 2001-03-06 | Guorong Chin | Method to detect proteins |
US6787330B1 (en) | 1999-01-28 | 2004-09-07 | University Of Geneva | Method and kit for identifying or characterizing polypeptides |
AU773291B2 (en) | 1999-03-10 | 2004-05-20 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | UPA, a universal protein array system |
US20020090673A1 (en) | 2000-01-31 | 2002-07-11 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
WO2001078652A2 (en) | 2000-04-14 | 2001-10-25 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
US20020110843A1 (en) | 2000-05-12 | 2002-08-15 | Dumas David P. | Compositions and methods for epitope mapping |
EP1301632A2 (en) | 2000-07-19 | 2003-04-16 | Pointilliste, Inc. | Nested sorting and high throughput screening |
GB0022978D0 (en) | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
US7142296B2 (en) | 2000-10-30 | 2006-11-28 | Sru Biosystems, Inc. | Method and apparatus for detecting biomolecular interactions |
DE10054055A1 (en) | 2000-10-31 | 2002-05-23 | Nmi Univ Tuebingen | Methods for analyzing proteins |
WO2002039083A2 (en) | 2000-11-08 | 2002-05-16 | Science & Technology Corporation @ Unm | Fluorescence and fret based assays for biomolecules on beads |
GB0103389D0 (en) * | 2001-02-12 | 2001-03-28 | Novartis Ag | Organic compounds |
AU2002338428A1 (en) | 2001-04-20 | 2002-11-05 | Carnegie Mellon University | Methods and systems for identifying proteins |
US20030044862A1 (en) | 2001-06-22 | 2003-03-06 | The Board Of Trustees Of The Leland Stanford Jr. University | Diagnostic marker for tumor hypoxia and prognosis |
IL159550A0 (en) | 2001-06-26 | 2004-06-01 | Mds Proteomics Inc | Methods and systems for identifying kinases, phosphatases and substrates thereof |
CA2457408A1 (en) | 2001-07-13 | 2003-01-23 | Pharmacopeia, Inc. | System and method for aqueous solubility prediction |
US20030143612A1 (en) | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
WO2003016904A2 (en) | 2001-08-13 | 2003-02-27 | Campbell Douglas A | Peptide sequence tags and method of using same |
US20050153298A1 (en) * | 2001-10-23 | 2005-07-14 | Gembitsky Dmitry S. | Protein micro-arrays and multi-layered affinity interaction detection |
GB0200595D0 (en) | 2002-01-11 | 2002-02-27 | Oxford Glycosciences Uk Ltd | Quantitation of differential expression |
US7618788B2 (en) | 2002-05-10 | 2009-11-17 | Millipore Corporation | Proteome epitope tags and methods of use thereof in protein modification analysis |
US7460960B2 (en) | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
US20060014212A1 (en) | 2002-05-10 | 2006-01-19 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
WO2004074452A2 (en) | 2003-02-19 | 2004-09-02 | The Regents Of The University Of California | Multiplex mapping of protein interactions |
WO2005050224A2 (en) | 2003-11-13 | 2005-06-02 | Epitome Biosystems Inc. | Small molecule and peptide arrays and uses thereof |
US7855057B2 (en) | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
US20100331200A1 (en) | 2006-03-31 | 2010-12-30 | Gordon Neal F | Post translational modification pattern analysis |
-
2003
- 2003-11-13 US US10/712,425 patent/US7460960B2/en not_active Expired - Fee Related
-
2004
- 2004-11-15 AU AU2004292226A patent/AU2004292226B2/en not_active Ceased
- 2004-11-15 JP JP2006539990A patent/JP2007511837A/en active Pending
- 2004-11-15 CA CA002545899A patent/CA2545899A1/en not_active Abandoned
- 2004-11-15 WO PCT/US2004/038283 patent/WO2005050223A2/en active Application Filing
- 2004-11-15 EP EP04811121A patent/EP1683065A2/en not_active Ceased
-
2008
- 2008-05-23 US US12/154,664 patent/US7964362B2/en not_active Expired - Fee Related
- 2008-09-25 AU AU2008227063A patent/AU2008227063A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997007132A1 (en) * | 1995-08-15 | 1997-02-27 | Commonwealth Scientific And Industrial Research Organisation | Epitope tagging system |
US20020137119A1 (en) * | 2001-01-14 | 2002-09-26 | Katz Emil Israel | Peptides representative of polypeptides of interest and antibodies directed thereagainst, and methods, systems and kits for generating and utilizing each |
WO2004046164A2 (en) * | 2002-05-10 | 2004-06-03 | Engeneos, Inc. | Unique recognition sequences and methods of use thereof in protein analysis |
Non-Patent Citations (1)
Title |
---|
LIU AGATHA H ET AL: "Motif-based construction of a functional map for mammalian olfactory receptors.", GENOMICS, vol. 81, no. 5, May 2003 (2003-05-01), pages 443 - 456, XP002336906, ISSN: 0888-7543 * |
Also Published As
Publication number | Publication date |
---|---|
AU2008227063A1 (en) | 2008-10-16 |
US7964362B2 (en) | 2011-06-21 |
JP2007511837A (en) | 2007-05-10 |
US20090023157A1 (en) | 2009-01-22 |
CA2545899A1 (en) | 2005-06-02 |
AU2004292226B2 (en) | 2008-06-26 |
AU2004292226A1 (en) | 2005-06-02 |
EP1683065A2 (en) | 2006-07-26 |
US7460960B2 (en) | 2008-12-02 |
US20040180380A1 (en) | 2004-09-16 |
WO2005050223A2 (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005050223A3 (en) | Proteome epitope tags and methods of use thereof in protein modification analysis | |
WO2005078453A3 (en) | Proteome epitope tags and methods of use thereof in protein modification analysis | |
WO2004046164A3 (en) | Unique recognition sequences and methods of use thereof in protein analysis | |
GB2396993B (en) | Intelligent spam detection system using an updateable neural analysis engine | |
WO2005050224A3 (en) | Small molecule and peptide arrays and uses thereof | |
EP2053406A3 (en) | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | |
WO2003077851A3 (en) | Compounds and methods for analyzing the proteome | |
WO2004064972A3 (en) | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | |
DE60222427D1 (en) | BUFFER ARRAYS FOR THE DETECTION OF BIOMOLECULES BASED ON ITS ISOELECTRIC POINT | |
AU2002338348A1 (en) | Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents | |
DE60319973D1 (en) | DISTRIBUTABLE SENSOR WITH IMPROVED SAMPLE INLET | |
EP1668338A4 (en) | Automated cytological sample classification | |
WO2004057341A3 (en) | Cvd assay | |
WO2019139980A8 (en) | Methods for measuring analyte and/or protein in biological samples | |
FI20021149A0 (en) | The probe system, the probe system receiver and the signal processing method in the probe receiver | |
AU2003237282A1 (en) | Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry | |
DE60323803D1 (en) | Device for error detection | |
EP1532173A4 (en) | Protein analysis | |
NO20033380L (en) | Resonance antenna for detection or identification | |
AU2003254298A1 (en) | Species specific dna detection | |
ITRE20030069A1 (en) | AUTOMATIC SYSTEM FOR SORTING AND PALLETIZING | |
PL1604209T3 (en) | Screening assay | |
AU2003304409A1 (en) | Evaluating protein signatures | |
AU2002254298A1 (en) | High accuracy protein identification | |
WO2004001377A3 (en) | Improved methods for performing differential capture proteomics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004811121 Country of ref document: EP Ref document number: 2006539990 Country of ref document: JP Ref document number: 2545899 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004292226 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004292226 Country of ref document: AU Date of ref document: 20041115 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004292226 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004811121 Country of ref document: EP |